Format

Send to

Choose Destination
Curr Opin HIV AIDS. 2017 Jan;12(1):69-76.

Malignancies in women with HIV infection.

Author information

1
aDepartment of Medicine, Section of Infectious Diseases, Atlanta VA Medical Center, Decatur, Georgia bDepartment of Medicine, Section of Infectious Diseases and Health Services Research, Baylor College of Medicine, Houston, Texas, USA.

Abstract

PURPOSE OF REVIEW:

To review current knowledge of different cancer states affecting women with HIV infection.

RECENT FINDINGS:

With improved survival of persons with HIV in the post-cART era, the landscape of malignancies in this population has greatly changed with fewer AIDS-defining malignancies (ADM) and a growing number of non-AIDS defining malignancies (NADM). Women, however, continue to represent a vulnerable population at risk for certain ADM and NADM such as cervical, anal, and breast cancer. Human papillomavirus-mediated cancers disproportionately burden women in resource-poor settings such as sub-Saharan Africa. For cancers such as Kaposi's sarcoma, lung cancer, liver cancer, and colorectal cancer, women share a lower burden of disease compared with their male counterparts. However, there remains a dearth of evidence characterizing these disease states specifically among women.

SUMMARY:

Cancer in women with HIV continues to be a major source of morbidity and mortality worldwide, especially in low-income countries. Screening strategies, primary prevention through vaccination against human papillomavirus and viral hepatitis, and treatment for HIV with combined antiviral therapy remain cornerstones in cancer prevention.

PMID:
27849632
PMCID:
PMC5568069
DOI:
10.1097/COH.0000000000000332
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center